Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Anisodine Hydrobromide for Episodic Migraine
NCT05416476Phase 3Recruiting
- Sponsor
- Second Affiliated Hospital of Zhejiang University School of Medicine
- Start
- Oct 2023
- Primary completion
- Oct 2025
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 3 trial of anisodine in episodic migraine, sponsored by Second Affiliated Hospital of Zhejiang University School of Medicine. Started Oct 2023; status: recruiting.
02
Drugs
anisodine
03
Conditions
episodic migraine
Beyond the preview
Go deeper on NCT05416476.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05416476.